Use of prophage free host for achieving homogenous population of bacteriophages: New findings

Virus Research

Volumn 169, Issue 1, 2012, Pages 182-187

  Nirmal Kumar, G P ^a   Sundarrajan, Sudarson ^a   Paul, Vivek Daniel ^a,b   Nandini, S ^a   Saravanan, R Sanjeev ^a   Hariharan, Sukumar ^a   Sriram, Bharathi ^a   Padmanabhan, Sriram ^a  

^a Gangagen Biotechnologies Pvt Ltd   (India)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Bacteriophages; Complementation; Endolysin; Prophages; RN4220; Superinfection immunity; VegII promoter

Indexed keywords

VIRUS PROTEIN;

ARTICLE; BACTERIOPHAGE; BACTERIOPHAGE 44AHJD; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROPHAGE; STAPHYLOCOCCUS AUREUS; VIRION; VIROGENESIS;

ANIMALS; BACTERIOLYSIS; BACTERIOPHAGES; ENDOPEPTIDASES; HUMANS; MICROSCOPY, ELECTRON, TRANSMISSION; PROPHAGES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VIRION;

STAPHYLOCOCCUS; STAPHYLOCOCCUS PHAGE 44AHJD;

EID: 84867206695     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2012.07.026     Document Type: Article

References (44)

1. Ackermann H.W. 5500 phages examined in the electron microscope. Archives of Virology 2007, 152:227-243.
2. Aucken H.M., Westwell K. Reaction difference rule for phage typing of Staphylococcus aureus at 100 times the routine test dilution. Journal of Clinical Microbiology 2002, 40:292-293.
3. Bae T., Baba T., Hiramatsu K., Schneewind O. Prophages of Staphylococcus aureus Newman and their contribution to virulence. Molecular Microbiology 2006, 62:1035-1047.
4. Bastos M.C.F., Coutinho B.G., Coelho M.L.V. Lysostaphin: a staphylococcal bacteriolysin with potential clinical applications. Pharmaceuticals 2010, 3:1139-1161.
5. Brussow H., Canchaya C., Hardt W.D. Phages and the evolution of bacterial pathogens: from genomic rearrangements to lysogenic conversion. Microbiology and Molecular Biology Reviews 2004, 68:560-602.
6. Bruttin A., Brüssow H. Human volunteers receiving Escherichia coli phage T4 orally: a safety test of phage therapy. Antimicrobial Agents and Chemotherapy 2005, 49:2874-2878.
7. Chambers H.F., Deleo F.R. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nature Reviews Microbiology 2009, 7:629-641.
8. Chaturvedi D., Chakravorty M. Restriction-modification system in bacteriophage MB 78. Biochemical and Biophysical Research Communications 2003, 303:884-890.
9. Chen F., Wang K., Stewart J., Belas R. Induction of multiple prophages from a marine bacterium: a genomic approach. Applied and Environment Microbiology 2006, 72:4995-5001.
10. Chopin M.C., Chopin A., Bidnenko E. Phage abortive infection in lactococci: variations on a theme. Current Opinion in Microbiology 2005, 8:473-479.
11. Czyz A., Marcin L., Wrobel B., Wegrzyn G. Inhibition of spontaneous induction of lambdoid prophages in Escherichia coli cultures: simple procedures with possible biotechnological applications. BMC Biotechnology 2001, 1:1.
12. Diep B.A., Gill S.R., Chang R.F., Phan T.H., Chen J.H., Davidson M.G. Complete genome sequence of USA300, an epidemic clone of community-acquired methicillin-resistant Staphylococcus aureus. Lancet 2006, 367:731-739.
13. Fischetti V.A. Bacteriophage lysins as effective anti-bacterials. Current Opinion in Microbiology 2008, 11:393-400.
14. Frias M.J., Melo-Cristino J., Ramirez M. The autolysin LytA contributes to efficient bacteriophage progeny release in Streptococcus pneumoniae. Journal of Bacteriology 2009, 191:5428-5440.
15. Georke C., Wirtz C., Flukiger U., Wolz C. Extensive phage dynamics in S. aureus contributes to adaptation to the human host during infection. Molecular Microbiology 2006, 61:1673-1685.
16. Gill S.R., Fouts D.E., Archer G.L., Mongodin E.F., Deboy R.T., Ravel J. Insights on evolution of virulence and resistance from the complete genome analysis of an early methicillin-resistant Staphylococcus aureus strain and a biofilm-producing methicillin-resistant Staphylococcus epidermidis strain. Journal of Bacteriology 2005, 187:2426-2438.
17. Goerke C., Pantucek R., Holtfreter S., Schulte B., Zink M., Grumann D., Bröker B.M., Doskar J., Wolz C. Diversity of prophages in dominant staphylococcus aureus clonal lineages. Journal of Bacteriology 2009, 191:3462-3468.
18. Gottesman M. Bacteriophage λ: the untold story. Journal of Molecular Biology 1999, 293:177-180.
19. Jayasheela M., Sriram B., Padmanabhan S. Defined Dose Therapeutic Phage 2005, International publication number WO2005/046579 A2.
20. Kutateladze M., Adamia R. Bacteriophages as potential new therapeutics to replace or supplement antibiotics. Trends in Biotechnology 2010, 28:591-595.
21. Kutter E. Phage host range and efficiency of plating. Methods in Molecular Biology 2009, 501:141-149.
22. Lindsay J.A. Chapter 3: S. aureus evolution: lineages and mobile genetic elements. Staphylococcus: Molecular Genetics 2008, Caister Academic Press, Norfolk, UK, pp. 45-70. J.A. Lindsay (Ed.).
23. Maniatis T., Sambrook J., Fritsch E.F. Molecular Cloning: A Laboratory Manual 1989, Cold Spring Harbor Laboratory Press, USA. second ed.
24. McDonald J.E., Smith D.L., Fogg P.C.M., McCarthy A.J., Allison H.E. High-throughput method for rapid induction of prophages from lysogens and its application in the study of shiga toxin-encoding Escherichia coli strains. Applied and Environment Microbiology 2010, 76:2360-2365.
25. McShan W.M. Bacteriophages of Group A streptococci. Gram-Positive Pathogens 2000, 105-116. ASM Press, Washington DC, Chapter 11. V.A. Fischeeti, R.A. Novick, J.J. Ferretti, D.A. Portnoy, J.I. Rood (Eds.).
26. Navarre W.W., Ton-That H., Faull K.F., Schneewind O. Multiple enzymatic activities of the murein hydrolase from staphylococcal phage f11. Journal of Biological Chemistry 1999, 274:15847-15856.
27. Novick R.P. Mobile genetic elements and bacterial toxinoses: the superantigen-encoding pathogenicity islands of Staphylococcus aureus. Plasmid 2003, 49:93-105.
28. O'Flaherty S., Coffey A., Edwards R., Meaney W., Fitzgerald G.F., Ross R.P. Genome of Staphylococcal phage K: a new lineage of myoviridae infecting Gram-positive bacteria with a low G+C content. Journal of Bacteriology 2004, 186:2862-2871.
29. Parisien A., Allain B., Zhang J., Mandeville R., Lan C.Q. Novel alternatives to antibiotics: bacteriophages, bacterial cell wall hydrolases, and antimicrobial peptides. Journal of Applied Microbiology 2008, 104:1-13.
30. Paul V.D., Sudararajan S., Saravanan S.R., Sukumar H., Kempashanaiah N., Padmanabhan S., Sriram B., Ramachandran J. Lysis-deficient phages as novel therapeutic agents for controlling bacterial infection. BMC Microbiology 2011, 11:195.
31. Paul V.D., Rajagopalan S.S., Sundarrajan S., George S.E., Asrani J.Y., Pillai R., Chikkamadaiah R., Durgaiah M., Sriram B., Padmanabhan S. A novel bacteriophage tail-associated muralytic enzyme (TAME) from phage k and its development into a potent antistaphylococcal protein. BMC Microbiology 2011, 11:226.
32. Rakhuba D.V., Kolomeits E.I., Szwajcer D.E., Novick G.I. Bacteriophage receptors, mechanism of phage adsorption and penetration into host cell. Polish Journal of Microbiology 2010, 59:145-155.
33. Sau K., Gupta S.K., Sau S., Ghosh T.C. Synonymous codon usage bias in 16 Staphylococcus aureus phages: implication in phage therapy. Virus Research 2005, 113:123-131.
34. Skurnik M., Pajunen M., Kiljunen S. Biotechnological challenges of phage therapy. Biotechnology Letters 2007, 29:995-1003.
35. Tao L., Wu X., Sun B. Alternative sigma factor sh modulates prophage integration and excision in Staphylococcus aureus. PLoS Pathogens 2010, 6:1-11.
36. van Wamel W.J., Rooijakkers S.H., Ruyken M., van Kessel K.P., van Strijp J.A. The innate immune modulators staphylococcal complement inhibitor and chemotaxis inhibitory protein of Staphylococcus aureus are located on beta-hemolysin-converting bacteriophages. Journal of Bacterialogy 2006, 188:1310-1315.
37. Vipra A.A., Desai S.N., Roy P., Patil R., Raj J.M., Narasimhaswamy N., Paul V.D., Chikkamadaiah R., Sriram B. Antistaphylococcal activity of bacteriophage derived chimeric protein P128. BMC Microbiology 2012, 12:41.
38. Vybiral D., Takáč M., Loessner M., Witte A., Ahsen U.V., Bläsi U. Complete nucleotide sequence and molecular characterization of two lytic Staphylococcus aureus phages: 44AHJD and P68. FEMS Microbiology Letters 2003, 219:275-283.
39. Waldron D.E., Lindsay J.A. Sau1: a novel lineage-specific type i restriction-modification system that blocks horizontal gene transfer into Staphylococcus aureus and between S. aureus isolates of different lineages. Journal of Bacteriology 2006, 188:5578-5585.
40. Wann E.R., Dassy B., Fournier J.M., Foster T.J. Genetic analysis of the cap5 locus of Staphylococcus aureus. FEMS Microbiology Letters 1999, 170:97-103.
41. Wirtz C., Witte W., Wolz C., Goerke C. Transcription of the phage-encoded Panton-Valentine leukocidin of Staphylococcus aureus is dependent on the phage life-cycle and on the host background. Microbiology 2009, 155:3491-3499.
42. Wiśniewska K., Garbacz K., Piechowicz L. Bacteriophage types of methicillin-resistant Staphylococcus aureus strains isolated in 2005-2006 in the Gdańsk area and their resistance to other antibiotics. Medycyna Doswiadczalna i Mikrobiologia 2007, 59:279-285.
43. Xia G., Corrigan R.M., Winstel V., Goerke C., Gründling A., Peschel A. Wall Teichoic acid-dependent adsorption of Staphylococcal siphovirus and myovirus. Journal of Bacteriology 2011, 193:4006-4009.
44. Yue W.-F., Du M., Zhu M.-J. High temperature in combination with uv irradiation enhances horizontal transfer of stx2 Gene from E. coli O157:H7 to non-pathogenic E. coli. PLoS ONE 2012, 7:1-6.